OpenScience.ink

1 week ago • EClinicalMedicine

Comparing GLP-1 drugs and mineralocorticoid blockers as fourth-choice treatments for hard-to-control high blood pressure in overweight or obese patientsComparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA.

🥈 Top 2% JournalArticle

1 week ago • Arthroplasty today

Weight Loss Before Joint Replacement Surgery Using New Glucagon-Like Peptide-1 MedicinesPreoperative Weight Loss Before Total Joint Arthroplasty Using Novel Glucagon-Like Peptide-1 Agonists.

📖 Top 20% JournalArticle

2 weeks ago • Frontiers in endocrinology

Use of glucagon-like peptide-1 drugs before hospital does not lower opioid use but is linked to shorter hospital stays after joint replacement surgeryPrehospital glucagon-like peptide-1 receptor agonists are not associated with reduced inpatient opioid exposure but with shorter hospital length of stay after total joint arthroplasty.

🎖️ Top 10% JournalArticle

2 weeks ago • Frontiers in gastroenterology (Lausanne, Switzerland)

Safety, benefits, and anti-inflammatory actions of glucagon-like peptide 1 receptor treatments in inflammatory bowel diseaseGlucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms.

📖 Top 50% JournalArticle

2 weeks ago • European journal of preventive cardiology

New Diabetes Drugs and the Risk of Atrial Fibrillation in People with Type 2 DiabetesSodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Incident Atrial Fibrillation in Type 2 Diabetes: A Population-Based Target Trial Emulation.

🥉 Top 5% JournalArticle

2 weeks ago • Medicine

Tirzepatide helps hard-to-treat diabetes in an adult woman with Prader-Willi syndromeCase report: Tirzepatide-responsive refractory diabetes mellitus in an adult female with prader-willi syndrome.

📖 Top 50% JournalCase Reports

2 weeks ago • Endocrinology, diabetes & metabolism

Heart and blood vessel outcomes of GLP-1 medicines compared to weight loss surgeryComparative Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus Bariatric Surgery: A Systematic Review and Network Meta-Analysis.

📖 Top 20% JournalSystematic Review

2 weeks ago • Acta biomaterialia

Local Exendin-4 Treatment May Reduce Bone Loss Around Implants by Restoring Bone BalanceLocal Administration of Exendin-4 Ameliorates Wear-Particle-Induced Periprosthetic Osteolysis by Rebalancing Bone Remodeling.

🥉 Top 5% JournalArticle

2 weeks ago • Current developments in nutrition

Specific Collagen Peptides May Improve Blood Sugar and Digestion by Affecting Hormones After Meals in People with Normal and Prediabetic Blood SugarSpecific Collagen Peptides Support Postprandial Metabolic Health by Modulating Incretin Hormones, Gastric Transit, and Glycemic Control in Participants with Normoglycemia and Prediabetes.

📖 Top 30% JournalArticle

2 weeks ago • Acta medica portuguesa

Changes in Antidiabetic Drug Prescribing Across Regions in Portugal Over Eight Years (2017–2024)[Regional Trends in Antidiabetic Drug Prescribing in Portugal: Eight Years of Nationwide Real-World Evidence (2017 - 2024) (TREND-8 REGIONS Study)].

English Abstract

2 weeks ago • Cardiology in review

Safety and Blood Sugar Control of Liraglutide Around Heart SurgerySafety and Glycemic Efficacy of Perioperative Liraglutide in Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

📖 Top 50% JournalArticle

2 weeks ago • Cureus

Possible Two-Phase Allergic Reaction After First Dose of Tirzepatide: A Case Report and Summary of Similar ReactionsSuspected Biphasic Anaphylaxis Following the First Known Dose of Tirzepatide: A Case Report and Brief Review of Reported Hypersensitivity Reactions.

Case Reports

2 weeks ago • SAGE open medical case reports

Open Eustachian Tube Problems After Fast Weight Loss Linked to Semaglutide Use: A Case ReportPatulous Eustachian tube dysfunction following rapid weight loss associated with semaglutide use: A case report.

Case Reports

2 weeks ago • Diabetes technology & therapeutics

Additional Treatments for People with Type 1 Diabetes Using Automated Insulin PumpsAdjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.

🥈 Top 2% JournalArticle

2 weeks ago • Obesity pillars

Correction to: Nutrition advice for treatments using glucagon-like peptides based on Asian Indian expert agreementCorrigendum to "Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation" [Obesity Pillars 19 (2026) 100296].

📖 Top 20% JournalPublished Erratum

2 weeks ago • Cell reports. Medicine

Potential of single, double, and triple GLP-1 treatments for managing liver scarring in MASHEmerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis.

🥈 Top 2% JournalArticle

2 weeks ago • Primary care diabetes

Use of combined basal insulin and GLP-1 drugs in Asians with type 2 diabetesUse of fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Asians with type 2 diabetes.

📖 Top 30% JournalArticle

2 weeks ago • Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

New Developments in Drugs Targeting Appetite and Metabolism Systems for Treating Obesity and Type 2 DiabetesRecent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.

Article

2 weeks ago • JCEM case reports

Tirzepatide treatment for low blood sugar after gastric bypass surgery: 3 case reportsTirzepatide for treatment of postbariatric hypoglycemia after Roux-en-Y gastric bypass: a report of 3 cases.

Case Reports

2 weeks ago • Kidney360

Lactic Acidosis and Normal-Blood-Sugar Ketoacidosis Linked to Metformin Triggered by a Diabetes Drug: A Case Report and ReviewMetformin-Associated Lactic Acidosis and Relative Euglycemic Ketoacidosis Precipitated by a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report and Literature Review.

📖 Top 20% JournalArticle

2 weeks ago • Current atherosclerosis reports

Oral Medications That Use Gut Hormones to Help Control WeightOral Incretin-Based Therapies for Weight Management.

🎖️ Top 10% JournalArticle

2 weeks ago • Frontiers in endocrinology

Unexplored Receptors in Diabetes: Their Role in Metabolism, Inflammation, and Drug DiscoveryOrphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development.

🎖️ Top 10% JournalArticle

2 weeks ago • BMJ medicine

Effectiveness and safety of weight-loss drugs based on glucagon-like peptide 1 in adults with overweight or obesity without diabetesComparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials.

Article

2 weeks ago • Pulmonary therapy

How Diabetes Drugs May Affect Immune and Metabolic Responses in Obese AsthmaImmunometabolic Modulation in Obese Asthma: How GLP-1 Receptor Agonists Could Influence Systemic and Pulmonary Immune Phenotypes.

📖 Top 20% JournalArticle

2 weeks ago • Pediatrics

Changes in Prescriptions of GLP-1 Medicines for Children Ages 8 to 11 with Obesity from 2019 to 2026Trends in GLP-1 Receptor Agonist Prescriptions for Children Ages 8 to 11 With Obesity: 2019-2026.

🥉 Top 5% JournalArticle

2 weeks ago • Nature

Current and Future Treatments for MASHCurrent therapeutic landscape and future treatment perspectives of MASH.

Article

2 weeks ago • Clinics in dermatology

Skin Reactions and Injection Site Problems Linked to Glucagon-like Peptide-1 Receptor Agonist UseGlucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions.

📖 Top 50% JournalArticle

2 weeks ago • Pharmaceutical research

Comparing the Structure and Lab Function of Synthetic Liraglutide with a Natural Reference VersionAn Orthogonal Framework for Higher-Order Structural and In Vitro Functional Comparability of Chemically Synthesized Liraglutide Relative to an rDNA-Origin Reference Product.

📖 Top 20% JournalArticle

2 weeks ago • Food research international (Ottawa, Ont.)

Self-Propelled Oral Delivery System Combining Rapeseed Protein Peptide and Liraglutide to Boost Insulin and Lower Blood SugarOral Janus nanomotor covalent conjugation rapeseed protein-derived DPP-IV inhibitory peptide and liraglutide: A self-propelled targeted delivery system for promoting insulin secretion and glucose-lowering.

🎖️ Top 10% JournalArticle

2 weeks ago • Pharmaceutical research

Semaglutide Absorption: Current Limits, New Formulation Advances, and Future PossibilitiesSemaglutide Bioavailability: Limitations, Formulation Innovation and Future Opportunities.

📖 Top 20% JournalArticle

← prevpage 7 of 14next →

Latest GLP-1 Therapies Research Papers